Importantly, the correlation of a high PI3K signaling score with ER-negativity contrasts with the known enrichment of PIK3CA mutations in ER-positive breast tumors [35,36], which were also reproduced by our analyses (Fig 3C and 3D). The gene discussed is PIK3CA; the disease is breast neoplasm.